Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hadengue

Showing results (151-160 of 225) with videos related to

Pageof 23
Sort By:
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]R Moreau, O Soubrane, A Hadengue, et al.
Journal of Hepatology|October 1, 1987
Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and ratsS S Lee, A Hadengue, R Moreau, et al.
Gastroenterology|April 1, 1994
The changing scene of hepatic vein thrombosis: recognition of asymptomatic casesA Hadengue, M Poliquin, V Vilgrain, et al.
Digestive Diseases and Sciences|January 9, 1999
Hepatitis G virus infection among liver graft recipients: anatomoclinical correlationsF Negro, L Rubbia-Brandt, E Giostra, et al.
Digestion|October 31, 2001
Ischemic colitis during pregnancy and contraceptive medicationJ L Frossard, L Spahr, P E Queneau, et al.
Hepatology (Baltimore, Md.)|May 9, 2001
Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspectiveF P Sarasin, P E Majno, J M Llovet, et al.
Journal of Hepatology|April 1, 1994
Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonistsP Sogni, T Soupison, R Moreau, et al.
Digestive Diseases and Sciences|May 1, 1995
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine AJ C Duclos-Vallée, A Hadengue, N Ganne-Carrié, et al.
Hepatology (Baltimore, Md.)|July 1, 1990
Abnormal pressor response to vasopressin in patients with cirrhosis: evidence for impaired buffering mechanismsR Moreau, A Hadengue, T Soupison, et al.
Lancet (London, England)|September 30, 1998
Tolcapone and fulminant hepatitisF Assal, L Spahr, A Hadengue, et al.
Pageof 23

Showing results (151-160 of 225) with videos related to

Sort By:
Pageof 23
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]R Moreau, O Soubrane, A Hadengue, et al.
Journal of Hepatology|October 1, 1987
Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and ratsS S Lee, A Hadengue, R Moreau, et al.
Gastroenterology|April 1, 1994
The changing scene of hepatic vein thrombosis: recognition of asymptomatic casesA Hadengue, M Poliquin, V Vilgrain, et al.
Digestive Diseases and Sciences|January 9, 1999
Hepatitis G virus infection among liver graft recipients: anatomoclinical correlationsF Negro, L Rubbia-Brandt, E Giostra, et al.
Digestion|October 31, 2001
Ischemic colitis during pregnancy and contraceptive medicationJ L Frossard, L Spahr, P E Queneau, et al.
Hepatology (Baltimore, Md.)|May 9, 2001
Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspectiveF P Sarasin, P E Majno, J M Llovet, et al.
Journal of Hepatology|April 1, 1994
Hemodynamic effects of acute administration of furosemide in patients with cirrhosis receiving beta-adrenergic antagonistsP Sogni, T Soupison, R Moreau, et al.
Digestive Diseases and Sciences|May 1, 1995
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine AJ C Duclos-Vallée, A Hadengue, N Ganne-Carrié, et al.
Hepatology (Baltimore, Md.)|July 1, 1990
Abnormal pressor response to vasopressin in patients with cirrhosis: evidence for impaired buffering mechanismsR Moreau, A Hadengue, T Soupison, et al.
Lancet (London, England)|September 30, 1998
Tolcapone and fulminant hepatitisF Assal, L Spahr, A Hadengue, et al.
Pageof 23